125 related articles for article (PubMed ID: 38616447)
1. Service Improvements and Workload Increases: Royal College of Radiologists (RCR) Re-Audit of Curative Intent Radiotherapy for Non-Small Cell Lung Cancer (NSCLC).
McAleese J; Drinkwater K;
Clin Oncol (R Coll Radiol); 2024 Jun; 36(6):e128-e136. PubMed ID: 38616447
[TBL] [Abstract][Full Text] [Related]
2. The Quality of Curative-intent Radiotherapy for Non-small Cell Lung Cancer in the UK.
McAleese J; Baluch S; Drinkwater K
Clin Oncol (R Coll Radiol); 2015 Sep; 27(9):498-504. PubMed ID: 26073694
[TBL] [Abstract][Full Text] [Related]
3. The Elderly are Less Likely to Receive Recommended Radical Radiotherapy for Non-small Cell Lung Cancer.
McAleese J; Baluch S; Drinkwater K; Bassett P; Hanna GG
Clin Oncol (R Coll Radiol); 2017 Sep; 29(9):593-600. PubMed ID: 28735769
[TBL] [Abstract][Full Text] [Related]
4. The Royal College of Radiologists National Vulvar Cancer Audit.
Baird P; Drinkwater K; Forrest J; Stewart AJ
Clin Oncol (R Coll Radiol); 2024 Jul; 36(7):e224-e234. PubMed ID: 38658266
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic Ablative Body Radiotherapy Versus Radical Radiotherapy: Comparing Real-World Outcomes in Stage I Lung Cancer.
Phillips I; Sandhu S; Lüchtenborg M; Harden S
Clin Oncol (R Coll Radiol); 2019 Oct; 31(10):681-687. PubMed ID: 31377081
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
[TBL] [Abstract][Full Text] [Related]
7. [Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].
Gong HY; Yu JM; Fu Z; Li BS; Li JB; Liu TH
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):54-7. PubMed ID: 16737623
[TBL] [Abstract][Full Text] [Related]
8. The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R): Real-World Data on Stage III Non-Small Cell Lung Cancer Patients Treated With Curative Chemoradiation.
Dieleman E; van der Woude L; van Os R; van Bockel L; Coremans I; van Es C; De Jaeger K; Knol HP; Kolff W; Koppe F; Pomp J; Reymen B; Schinagl D; Spoelstra F; Tissing-Tan C; van der Voort van Zyp N; van der Wel A; Wijsman R; Dielwart M; Wiegman E; Damhuis R; Belderbos J
Clin Lung Cancer; 2023 Mar; 24(2):130-136. PubMed ID: 36572596
[TBL] [Abstract][Full Text] [Related]
9. Population-based analysis of curative therapies in stage II non-small cell lung cancer: the role of radiotherapy in medically inoperable patients.
Moore S; Leung B; Wu J; Ho C
Radiat Oncol; 2020 Jan; 15(1):23. PubMed ID: 32000829
[TBL] [Abstract][Full Text] [Related]
10. PET/CT-based adaptive radiotherapy of locally advanced non-small cell lung cancer in multicenter yDEGRO ARO 2017-01 cohort study.
Mäurer M; Käsmann L; Fleischmann DF; Oertel M; Jazmati D; Medenwald D;
Radiat Oncol; 2022 Feb; 17(1):29. PubMed ID: 35139856
[TBL] [Abstract][Full Text] [Related]
11. Stage migration in planning PET/CT scans in patients due to receive radiotherapy for non-small-cell lung cancer.
Geiger GA; Kim MB; Xanthopoulos EP; Pryma DA; Grover S; Plastaras JP; Langer CJ; Simone CB; Rengan R
Clin Lung Cancer; 2014 Jan; 15(1):79-85. PubMed ID: 24238934
[TBL] [Abstract][Full Text] [Related]
12. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy patterns of care for stage I and II non-small cell lung cancer in Sydney, Australia.
Nguyen AD; Wong W; Beydoun N; Mohan S; Shafiq J; Vinod SK
J Med Imaging Radiat Oncol; 2019 Feb; 63(1):131-141. PubMed ID: 30281917
[TBL] [Abstract][Full Text] [Related]
14. Quantitative modifications of TNM staging, clinical staging and therapeutic intent by FDG-PET/CT in patients with non small cell lung cancer scheduled for radiotherapy--a retrospective study.
Abramyuk A; Appold S; Zöphel K; Hietschold V; Baumann M; Abolmaali N
Lung Cancer; 2012 Nov; 78(2):148-52. PubMed ID: 22922126
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the Implementation of Lung Cancer Consensus Statements From the Royal College of Radiologists in 2021; Progress and Barriers.
McAleese J; Tumelty K; Baluch S; Powell C; Drinkwater K
Clin Oncol (R Coll Radiol); 2022 Nov; 34(11):e463-e471. PubMed ID: 36109283
[TBL] [Abstract][Full Text] [Related]
16. Concurrent versus sequential chemoradiotherapy for unresectable locally advanced stage III non-small cell lung cancer: Retrospective analysis in a single United Kingdom cancer centre.
Spencer A; Williams J; Samuel R; Boon IS; Clarke K; Jain P
Cancer Treat Res Commun; 2021; 29():100460. PubMed ID: 34598059
[TBL] [Abstract][Full Text] [Related]
17. Differential Relapse Patterns for Non-small Cell Lung Cancer Subtypes Adenocarcinoma and Squamous Cell Carcinoma: Implications for Radiation Oncology.
McAleese J; Taylor A; Walls GM; Hanna GG
Clin Oncol (R Coll Radiol); 2019 Oct; 31(10):711-719. PubMed ID: 31351746
[TBL] [Abstract][Full Text] [Related]
18. Predicting the Risk of Disease Recurrence and Death Following Curative-intent Radiotherapy for Non-small Cell Lung Cancer: The Development and Validation of Two Scoring Systems From a Large Multicentre UK Cohort.
Evison M; Barrett E; Cheng A; Mulla A; Walls G; Johnston D; McAleese J; Moore K; Hicks J; Blyth K; Denholm M; Magee L; Gilligan D; Silverman S; Hiley C; Qureshi M; Clinch H; Hatton M; Philipps L; Brown S; O'Brien M; McDonald F; Faivre-Finn C
Clin Oncol (R Coll Radiol); 2021 Mar; 33(3):145-154. PubMed ID: 32978027
[TBL] [Abstract][Full Text] [Related]
19. Non-small cell lung cancer stage migration as a function of wait times from diagnostic imaging: A pooled analysis from five international centres.
Bissonnette JP; Sun A; Grills IS; Almahariq MF; Geiger G; Vogel W; Sonke JJ; Everitt S; Manus MM
Lung Cancer; 2021 May; 155():136-143. PubMed ID: 33819859
[TBL] [Abstract][Full Text] [Related]
20. High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancer.
Everitt S; Herschtal A; Callahan J; Plumridge N; Ball D; Kron T; Schneider-Kolsky M; Binns D; Hicks RJ; MacManus M
Cancer; 2010 Nov; 116(21):5030-7. PubMed ID: 20623786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
